Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.
GVAX免疫疗法后甲状腺球蛋白抗体的产生与生存期延长相关
期刊:International Journal of Cancer
影响因子:4.7
doi:10.1002/ijc.28973
De Remigis Alessandra, de Gruijl Tanja D, Uram Jennifer N, Tzou Schey-Cherng, Iwama Shintaro, Talor Monica V, Armstrong Todd D, Santegoets Saskia J A M, Slovin Susan F, Zheng Lei, Laheru Daniel A, Jaffee Elizabeth M, Gerritsen Winald R, van den Eertwegh Alfons J M, Le Dung T, Caturegli Patrizio